Administration of an antibody against apoptosis inhibitor of macrophage prevents aortic aneurysm progression in mice
- PMID: 38982113
- PMCID: PMC11233551
- DOI: 10.1038/s41598-024-66791-7
Administration of an antibody against apoptosis inhibitor of macrophage prevents aortic aneurysm progression in mice
Abstract
Apoptosis inhibitor of macrophage (AIM) is known to induce apoptosis resistance in macrophages and to exacerbate chronic inflammation, leading to arteriosclerosis. The role of AIM in aortic aneurysm (AA) remains unknown. This study examined the effects of an anti-AIM antibody in preventing AA formation and progression. In apolipoprotein E-deficient mice, AA was induced by subcutaneous angiotensin II infusion. Mice were randomly divided into two groups: (i) AIM group; weekly anti-murine AIM monoclonal antibody injection (n = 10), and (ii) IgG group; anti-murine IgG antibody injection as control (n = 14). The AIM group, compared with the IgG group, exhibited reduced AA enlargement (aortic diameter at 4 weeks: 2.1 vs. 2.7 mm, respectively, p = 0.012); decreased loss of elastic lamellae construction; reduced expression levels of IL-6, TNF-α, and MCP-1; decreased numbers of AIM-positive cells and inflammatory M1 macrophages (AIM: 1.4 vs. 8.0%, respectively, p = 0.004; M1 macrophages: 24.5 vs. 55.7%, respectively, p = 0.017); and higher expression of caspase-3 in the aortic wall (22.8 vs. 10.5%, respectively, p = 0.019). Our results suggest that administration of an anti-AIM antibody mitigated AA progression by alleviating inflammation and promoting M1 macrophage apoptosis.
Keywords: Aortic aneurysm; Apoptosis inhibitor of macrophage; Inflammation; Macrophage.
© 2024. The Author(s).
Conflict of interest statement
The authors declare no competing interests.
Figures








Similar articles
-
The oral administration of clarithromycin prevents the progression and rupture of aortic aneurysm.J Vasc Surg. 2018 Dec;68(6S):82S-92S.e2. doi: 10.1016/j.jvs.2017.12.047. Epub 2018 Mar 14. J Vasc Surg. 2018. PMID: 29550174
-
Azelnidipine suppresses the progression of aortic aneurysm in wild mice model through anti-inflammatory effects.J Thorac Cardiovasc Surg. 2013 Dec;146(6):1501-8. doi: 10.1016/j.jtcvs.2013.02.073. Epub 2013 Mar 25. J Thorac Cardiovasc Surg. 2013. PMID: 23535154
-
Intravenous administration of mesenchymal stem cells prevents angiotensin II-induced aortic aneurysm formation in apolipoprotein E-deficient mouse.J Transl Med. 2013 Jul 22;11:175. doi: 10.1186/1479-5876-11-175. J Transl Med. 2013. PMID: 23875706 Free PMC article.
-
Current Pharmacological Management of Aortic Aneurysm.J Cardiovasc Pharmacol. 2021 Aug 1;78(2):211-220. doi: 10.1097/FJC.0000000000001054. J Cardiovasc Pharmacol. 2021. PMID: 33990514 Review.
-
Diverse roles of macrophage polarization in aortic aneurysm: destruction and repair.J Transl Med. 2018 Dec 13;16(1):354. doi: 10.1186/s12967-018-1731-0. J Transl Med. 2018. PMID: 30545380 Free PMC article. Review.
References
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Molecular Biology Databases
Research Materials
Miscellaneous